Polymorphic variation ath the 202 locus in lGFBP-3: Serum levels of insulin-like growth factors, interactions with known regulations and breast cancer risk

Eva Schernhammer; S.E. Hankinson; D.J. Hunter; M.J. Blouin; M.N. Pollak

Polymorphic variation ath the 202 locus in lGFBP-3: Serum levels of insulin-like growth factors, interactions with known regulations and breast cancer risk

Eva Schernhammer, S.E. Hankinson, D.J. Hunter, M.J. Blouin, M.N. Pollak

Radiation, Safety and Applications

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	1149
Seitenumfang	1
Fachzeitschrift	Cancer Epidemiology Biomarkers & Prevention
Publikationsstatus	Veröffentlicht - 2002

Research Field

Biosensor Technologies

Schlagwörter

Seibersdorf
serum
insulin
breast
cancer
risk

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

Diese Publikation zitieren

@article{f15b2bc08b0149b88304d7672c933f8a,

title = "Polymorphic variation ath the 202 locus in lGFBP-3: Serum levels of insulin-like growth factors, interactions with known regulations and breast cancer risk",

keywords = "Seibersdorf, serum, insulin, breast, cancer, risk, Seibersdorf, serum, insulin, breast, cancer, risk",

author = "Eva Schernhammer and S.E. Hankinson and D.J. Hunter and M.J. Blouin and M.N. Pollak",

year = "2002",

language = "English",

pages = "1149",

journal = "Cancer Epidemiology Biomarkers & Prevention",

issn = "1055-9965",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Polymorphic variation ath the 202 locus in lGFBP-3: Serum levels of insulin-like growth factors, interactions with known regulations and breast cancer risk

AU - Schernhammer, Eva

AU - Hankinson, S.E.

AU - Hunter, D.J.

AU - Blouin, M.J.

AU - Pollak, M.N.

PY - 2002

Y1 - 2002

KW - Seibersdorf

KW - serum

KW - insulin

KW - breast

KW - cancer

KW - risk

KW - Seibersdorf

KW - serum

KW - insulin

KW - breast

KW - cancer

KW - risk

M3 - Article

SN - 1055-9965

SP - 1149

JO - Cancer Epidemiology Biomarkers & Prevention

JF - Cancer Epidemiology Biomarkers & Prevention

ER -